Surgery Partners, Inc. (SGRY)
USD 21.31
(1.04%)
USD 21.31
(1.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 529.4 Million USD | -7.91% |
| 2022 | 574.9 Million USD | 16.99% |
| 2021 | 491.4 Million USD | 29.38% |
| 2020 | 379.8 Million USD | -10.38% |
| 2019 | 423.8 Million USD | 3.36% |
| 2018 | 410.02 Million USD | 25.23% |
| 2017 | 327.41 Million USD | 0.98% |
| 2016 | 324.24 Million USD | 11.59% |
| 2015 | 290.56 Million USD | 94.86% |
| 2014 | 149.11 Million USD | 29.94% |
| 2013 | 114.75 Million USD | 13.77% |
| 2012 | 100.86 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 144.4 Million USD | 47.37% |
| 2024 Q1 | 121.6 Million USD | -25.17% |
| 2023 Q2 | 154.1 Million USD | 15.0% |
| 2023 Q1 | 134 Million USD | -27.29% |
| 2023 FY | 529.4 Million USD | -7.91% |
| 2023 Q4 | 162.5 Million USD | -1.99% |
| 2023 Q3 | 165.8 Million USD | 7.59% |
| 2022 Q3 | 131.2 Million USD | -2.53% |
| 2022 Q2 | 134.6 Million USD | 7.85% |
| 2022 Q4 | 184.3 Million USD | 40.47% |
| 2022 FY | 574.9 Million USD | 16.99% |
| 2022 Q1 | 124.8 Million USD | -15.16% |
| 2021 FY | 491.4 Million USD | 29.38% |
| 2021 Q1 | 103.5 Million USD | -23.56% |
| 2021 Q3 | 122.5 Million USD | 3.55% |
| 2021 Q4 | 147.1 Million USD | 20.08% |
| 2021 Q2 | 118.3 Million USD | 14.3% |
| 2020 Q3 | 114.2 Million USD | 106.14% |
| 2020 FY | 379.8 Million USD | -10.38% |
| 2020 Q1 | 74.8 Million USD | -42.11% |
| 2020 Q4 | 135.4 Million USD | 18.56% |
| 2020 Q2 | 55.4 Million USD | -25.94% |
| 2019 Q1 | 90.7 Million USD | -30.99% |
| 2019 Q4 | 129.2 Million USD | 30.64% |
| 2019 Q3 | 98.9 Million USD | -5.81% |
| 2019 Q2 | 105 Million USD | 15.77% |
| 2019 FY | 423.8 Million USD | 3.36% |
| 2018 Q4 | 131.42 Million USD | 19.87% |
| 2018 Q1 | 90.05 Million USD | -25.97% |
| 2018 Q2 | 104.68 Million USD | 16.24% |
| 2018 Q3 | 109.64 Million USD | 4.74% |
| 2018 FY | 410.02 Million USD | 25.23% |
| 2017 Q3 | 81.28 Million USD | 13.06% |
| 2017 FY | 327.41 Million USD | 0.98% |
| 2017 Q4 | 121.64 Million USD | 49.64% |
| 2017 Q2 | 71.9 Million USD | -3.14% |
| 2017 Q1 | 74.23 Million USD | -19.09% |
| 2016 FY | 324.24 Million USD | 11.59% |
| 2016 Q3 | 81.28 Million USD | 0.57% |
| 2016 Q4 | 91.75 Million USD | 12.88% |
| 2016 Q2 | 80.82 Million USD | 14.86% |
| 2016 Q1 | 70.37 Million USD | -12.2% |
| 2015 Q2 | 71.26 Million USD | 4.24% |
| 2015 Q1 | 68.37 Million USD | 15.68% |
| 2015 FY | 290.56 Million USD | 94.86% |
| 2015 Q3 | 70.77 Million USD | -0.69% |
| 2015 Q4 | 80.14 Million USD | 13.24% |
| 2014 Q3 | 30.92 Million USD | 3.27% |
| 2014 Q1 | 26.1 Million USD | 0.0% |
| 2014 Q2 | 29.94 Million USD | 14.72% |
| 2014 FY | 149.11 Million USD | 29.94% |
| 2014 Q4 | 59.1 Million USD | 91.11% |
| 2013 FY | 114.75 Million USD | 13.77% |
| 2012 FY | 100.86 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 22.445% |
| Addus HomeCare Corporation | 339.87 Million USD | -55.763% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -334.273% |
| Amedisys, Inc. | 457.07 Million USD | -15.823% |
| American Oncology Network, Inc. | 66.05 Million USD | -701.429% |
| Astrana Health, Inc. | 214.95 Million USD | -146.281% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 11.09% |
| IMAC Holdings, Inc. | 3.84 Million USD | -13655.587% |
| biote Corp. | 127.48 Million USD | -315.271% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -2211.651% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | -22.528% |
| COMPASS Pathways plc | -242.93 Thousand USD | 218015.682% |
| DocGo Inc. | 178.95 Million USD | -195.836% |
| The Ensign Group, Inc. | 590.75 Million USD | 10.386% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -110.539% |
| InnovAge Holding Corp. | 132.06 Million USD | -300.866% |
| Assure Holdings Corp. | -2.19 Million USD | 24229.444% |
| The Joint Corp. | 107.14 Million USD | -394.075% |
| LifeStance Health Group, Inc. | 302.09 Million USD | -75.242% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 49500.688% |
| ModivCare Inc. | 446.95 Million USD | -18.447% |
| NewGenIvf Group Limited | 1.68 Million USD | -31378.459% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -10589.087% |
| Option Care Health, Inc. | 981.22 Million USD | 46.047% |
| P3 Health Partners Inc. | 31.63 Million USD | -1573.463% |
| P3 Health Partners Inc. | 31.63 Million USD | -1573.463% |
| The Pennant Group, Inc. | 61.9 Million USD | -755.168% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -37395.573% |
| Talkspace, Inc. | 74.38 Million USD | -611.75% |
| Talkspace, Inc. | 74.38 Million USD | -611.75% |
| The Oncology Institute, Inc. | 59.57 Million USD | -788.658% |
| The Oncology Institute, Inc. | 59.57 Million USD | -788.658% |